Sales Revenue Determinants for Generic Pharmaceutical Companies
Destrina Grace Simanjuntak
Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group
Raymond R. Tjandrawinata
Department of Business Development and Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica
September 26, 2011
We analyze several parameters that influence the amount of sales revenue in generic pharmaceutical companies in Indonesia. The parameters were firms’ one-year lagged of total new products (t-1), one-year lagged profitability (t-1), and market share of new products. Annual data of six large generic pharmaceutical companies were included in the model for a time period spanned from 2003 to 2010. The regression analysis method uses fixed effect models, with generalized least squares (GLS) method. The result shows that firms’ one-year lagged of total new product (t-1), one-year lagged profitability (t-1), and market share of new products to be positive and affect significantly the firms’ sales revenue in the pharmaceutical generic companies in Indonesia.
Number of Pages in PDF File: 11
Keywords: profitability, sales revenue, market share, new generic product, pharmaceutical generic companies
JEL Classification: A10, C23, G30, L21, M21working papers series
Date posted: September 26, 2011
© 2013 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo4 in 0.344 seconds